Sandra Levy
ARTICLES BY THIS AUTHOR
- 2/25/2020
NACDS’ Anderson urges Congress on DIR fee relief in op-ed
NACDS' Steve Anderson cited an analysis by Adam Fein, Drug Channels Institute CEO, that DIR fees reached $9.1 billion in 2019. - 2/25/2020
Sun Pharma introduces Riomet ER
Sun Pharma’s Riomet ER is the first and only liquid formulation of metformin for Type 2 diabetes patients. - 2/24/2020
International Isotopes gets FDA green light for generic sodium iodide
International Isotopes' sodium iodide I-131 is the only generic product of its type. - 2/24/2020
Perrigo, Catalent get FDA nod for 1st generic metered-dose inhaler in 20 years
ProAir HFA — one of the most commonly used rescue inhalers in the country — had a market value of approximately $1.4 billion for the previous 12 months, according to IQVIA. - 2/23/2020
Seqirus gets FDA nod for Fluad
Seqirus' Fluad Quadrivalent vaccine offers flu protection for adults 65 years old and older. - 2/23/2020
AAM, Biosimilars Council applaud FDA’s release of enhanced Purple Book
The AAM and Biosimilars Council said it will continue to call on policymakers to support legislation that would require all patents for the reference biologic to be listed in the FDA's Purple Book. - 2/23/2020
FDA approves Lundbeck’s Vyepti
Lundbeck’s Vyepti is the first and only intravenous preventive treatment for migraine. - 2/23/2020
United Therapeutics, DEKA get FDA OK for subcutaneous delivery system for Remodulin
The Remunity system to treat pulmonary arterial hypertension is expected to be available by July for specialty pharmacies. - 2/20/2020
Hy-Vee to expand Fast & Fresh Express banner with acquisition
Four Hy-Vee Fast & Fresh Express stores are set to open on March 20 in the Des Moines, Iowa metro area. - 2/19/2020
2019 was a very good year for generic drug approvals
In 2019, the FDA gave 1,014 generic drug final and tentative approvals.
